CCM
ABBV icon

Cinctive Capital Management’s AbbVie ABBV Stock Holding History

Cinctive Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,000
Closed -$4.86M – 501
2022
Q1 		$4.86M Buy
+30,000
New +$4.36M 0.18% 184
2021
Q4 		– Sell
-250,000
Closed -$27M – 525
2021
Q3 		$27M Buy
+250,000
New +$28.6M 1.32% 3

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cinctive Capital Management's ABBV Position: Q2 2026 in Review

Cinctive Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 71,352 shares worth $18M. The stake represents 0.66% of the portfolio and ranks #31 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in ABBV as recently as Q3 2025.

Cinctive Capital Management first reported a position in ABBV in Q4 2019 and has held it in 15 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cinctive Capital Management held 71,352 shares of AbbVie worth $18M as of Q2 2026.
  • AbbVie was a new Cinctive Capital Management position in Q2 2026.
  • AbbVie made up 0.66% of Cinctive Capital Management's portfolio in Q2 2026, its #31 holding.
  • Cinctive Capital Management first reported a position in AbbVie in Q4 2019 and has held it in 15 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.